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Master’s Paper Abstract 
The influence of a patient’s health literacy on his/her health has become a topic of increasing 
interest over the past decade.  Many studies have examined the effect of health literacy on disease 
understanding and health outcomes in multiple chronic diseases.  However, there is scarce literature 
exploring the role of health literacy in the field of ophthalmology, specifically glaucoma.   
This paper includes systematic review of the current literature examining the effect of provider 
communication interventions on the rate of glaucoma medication adherence in patients with low health 
literacy.  Of 89 titles identified for review, 86 were excluded based on population, intervention, 
outcome, or study design.  The three included studies were assessed for study design, potential for 
selection bias, measurement bias, and confounding.  All three studies were assigned an overall quality 
rating of fair based on these criteria.  Comparison of results was difficult due to varying definitions of 
compliance and the use of multifaceted educational programs.  However, the overall conclusion is that 
multifaceted interventions with both educational and behavioral aspects can improve glaucoma 
medication adherence by 9 to 19 percent.  While statistically significant, the clinical importance of this 
improvement is still unclear. 
 Based on the above results, a preliminary qualitative study using focus groups was designed to 
explore provider communications with low health literacy African American patients with glaucoma.  
The goal of the study is to attempt to understand how African Americans perceive medical information 
related to their glaucoma care and to then use that information to develop a tool for improving provider 
patient communication about glaucoma. 
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Systematic Review Abstract 
Purpose:  This review was designed to synthesize the published studies that examine provider patient 
communication interventions designed to decrease the rate of non-adherence in glaucoma patients. 
Methods:   A systematic review of relevant qualitative and quantitative studies was conducted.  
Medline, Cochrane databases, CINAHL, EMBASE, and ISI health were searched from inception to March 
2011 using MeSH and keyword terms.  The search was restricted to the English language.  Articles were 
selected based on the following criteria: glaucoma population, individual level educational intervention, 
and medication adherence outcome. Editorial and personal opinion articles were excluded. Studies were 
assigned a quality rating of poor, fair, or good.  Data was abstracted by a single author based on criteria 
developed by the United States Preventive Services Task Force (USPSTF). 
Results:  Three studies, two randomized controlled trials (RCTs) and one survey, met the inclusion 
criteria.  There was substantial heterogeneity of reported outcome analysis.  Both RCTs showed an 
improvement in medication adherence in groups that received a multifaceted intervention.  The survey 
found specific educational items but not total glaucoma knowledge to be associated with improved anti-
glaucoma medication adherence.  The authors concluded that multifaceted programs are likely to be 
more successful at improving adherence than education only interventions. 
Conclusion:  Although difficult to compare due to varied definitions of adherence, all three studies 
showed that multifaceted interventions at the provider patient level can improve adherence to topical 
ocular drop regimen in the glaucoma population. 
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Introduction 
The effects of health literacy on disease management and outcomes have been the focus of 
study for over a decade.  Health literacy centered interventions have been studied in multiple chronic 
diseases such as diabetes and human immunodeficiency virus (HIV) (1-4).  However, interventions for 
people with low health literacy have been slow to permeate the field of ophthalmology, and the effects 
of health literacy centered interventions have not been well studied in ophthalmologic diseases. Primary 
open angle glaucoma (POAG) is a chronic disease that relies on patient understanding of the disease 
process for compliance to lifelong anti-glaucoma drop instillation.  However, we lack literacy aids for 
glaucoma patients who have poor literacy skills and we lack tools to improve ophthalmologists’ ability to 
communicate effectively with low health literacy patients.  Additionally, the principles of chronic disease 
management that are important in the treatment of POAG are not widespread in the field of 
ophthalmology. 
Similar trends with low treatment adherence rates have been found in ophthalmology as in 
other fields of medicine (5).  The Glaucoma Adherence and Persistency Study (GAPS) examined 
medication adherence from the perspective of patient beliefs and experiences (5).  GAPS identified 
several modifiable barriers at the provider-patient level including lack of concern over disease 
progression and passive dependence on the provider.  Both of these barriers can be addressed by 
improving provider-patient communication. 
The American Medical Association (AMA) defines functional health literacy as the ability to read 
and understand written health information, oral health information, and the ability to act on such 
information (6).   Paasche-Orlow and Wolf proposed a basic conceptual model to describe the pathway 
between health literacy and health outcomes (7).   This model incorporates both patient and system 
level factors that influence health outcomes.  The model identifies several modifiable factors, specifically 
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at the patient-provider level.   Modifiable patient factors include knowledge and participation in decision 
making, while the provider factors are communication skills, teaching ability, time, and patient-centered 
care.  
 Patients with low health literacy have been shown to be less likely to ask their provider 
questions  and seek additional services or information.  In addition, patients with low health literacy are 
less likely to use preventive health services, more likely to have less knowledge about their chronic 
disease and have worse health outcomes (8).  Hironaka and Paasche-Orlow offer strategies to improve 
provider-patient communication by improving the decision making process (8).   These strategies, 
focused on improving the provider’s communication and teaching skills, instructed providers to use 
multiple forms of communication, such as written, graphic and oral; helped their patients ask questions; 
and confirmed that the patient actually understood the message (8).  
While many studies have examined the rate and potential causes of medication non-adherence, 
very little is known about how to actually improve patient understanding and adherence in 
ophthalmological diseases such as glaucoma.  Many of the current recommendations are based on other 
chronic diseases, such as diabetes or hypertension, but their effect on glaucoma is unknown.  The aim of 
this systematic review is to identify provider communication interventions to mitigate poor glaucoma 
medication adherence in patients with low health literacy.  
Methods 
Search Strategy 
 In collaboration with a medical librarian, Medline, Cochrane databases, CINAHL, EMBASE, and ISI 
Health were searched for relevant articles from inception through March 2011.  Both MeSH and 
keyword terms were used in literature searches with the search strategy listed in Appendix 1.  The 
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PubMed search was conducted using the limits Humans, Clinical Trial, Meta-Analysis, Randomized 
Controlled Trial, Review, Case Reports, Classical Article, Clinical Trial, Phase I, Clinical Trial, Phase II, 
Clinical Trial, Phase III, Clinical Trial, Phase IV, Comparative Study, Controlled Clinical Trial, Evaluation 
Studies, and English.  The reference lists of identified articles were searched for additional citations of 
interest. 
Study Selection and Data Extraction 
Title and abstracts of all papers identified by electronic and hand searches were assessed for 
inclusion criteria.  Full reports were obtained and assessed for all potentially eligible studies identified by 
title and abstract review.  The reviewer was not masked to the names of the investigators or journal of 
publication during assessment.  Results were evaluated for duplication from multiple databases.  Papers 
were examined for education based interventions for glaucoma patients at the individual level.  Studies 
were excluded based on population, intervention, outcome, or design.  Studies were also excluded if the 
intervention was at the population instead of individual level.  Papers that did not report on original 
research, such as editorials and reviews were excluded.  Outcomes of interest were patient 
understanding of disease and medication adherence.  Data were extracted from each paper by a single 
author (AB) onto data extraction forms.   
Study quality assessment 
 A form modified from the US Preventive Services Task Force guidelines for critical analysis was 
used for assessment (Appendix 2). A single author (AB) evaluated each included paper for study design, 
sample size and outcomes.  Studies were assessed for the potential for selection bias, measurement 
bias, and confounding.  Study quality was assessed on the following criteria: adequacy of source and 
sample population description, similarity of cases and controls at baseline, adequacy of measurement 
tool description, appropriateness of analysis, adequacy of results description and external validity.  Each 
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criterion was given a score of 1 for poor, 2 for fair, or 3 for good.   Overall study validity was rated as 
good, fair, or poor based on these criteria. Poor was defined as overall score of 6-10, fair as 11-14, and 
good as 15-18. 
Results 
The search identified eighty-nine titles for review (Figure 1).  Using the selection criteria stated 
above seventy-four articles were excluded by citation and abstract review. Of the fifteen articles 
selected for full-text review, twelve were excluded.  Seven papers, three reviews (9-11) and four 
editorials (12-15) were excluded on the basis of not reporting on original research. Two studies were 
excluded because they did not examine a population with glaucoma (16, 17), one did not contain a 
health literacy intervention (18), and two did not examine the effect on treatment adherence (19, 20).  
This resulted in three studies that examined the relationship between individual level education and 
compliance to glaucoma medication (21-23).  Two RCTs (21, 22) and one survey (23) were included in 
this review (Table 1).  All three studies were determined to be of fair quality (Table 2). 
Okeke Study 
Okeke et al performed a two phase randomized controlled trial to examine the effect of a 
multifaceted educational intervention on compliance to glaucoma medications (21).  Glaucoma patients 
seen at the Scheie Eye Institute and the Wilmer Eye Institute between November 2006 and June 2007 
were recruited to participate in the study.  Phase one of the study consisted of a prospective cohort 
study of patient compliance to glaucoma medication for three months.  After three months, patients 
with 75% compliance or less were included in phase two and randomized to the intervention or control 
group.  Medication adherence was measured by a previously validated Dosing Aid.  The intervention 
consisted of four parts: a ten minute educational video, an organized strategy discussion with the study 
coordinator, reminder telephone calls, and audio and visual alarms on the Dosing Aid. 
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Baseline adherence was similar between the intervention and control groups (54% in the 
intervention group versus 45% in the control group, P=0.10).  While the two groups were similar in most 
demographic and ocular aspects, the control group was significantly more likely have used ocular drops 
for less than a year (5.71% of the intervention group versus 29.0% of the control group, P<0.01).  The 
mean adherence rate significantly increased from 54% to 73% (P<0.01) for the intervention group while 
the change in mean adherence for the control group was not statistically significant (46% to 51%, 
P=0.19). 
Study Design 
 This study was a two phase randomized controlled trial (RCT).  External generalizability, often a 
limitation of RCTs due to the typical complexity of design and rigid exclusion criteria, was not an issue 
with this study which had a relatively pragmatic behavioral intervention.  In addition, there were 
relatively few exclusion criteria, related primarily to the participant’s ability to understand and use the 
Dosing Aid.  Criteria for phase two was a baseline adherence rate of 75% or less during phase one.  This 
design was used to maximize the chance of finding significant results. 
Selection of Study Population 
 Patients were selected from major academic centers which are likely a different population from 
the general population in which there is a higher percentage of patients with more advanced disease 
than in the general population.  Researchers specifically recruited patients shown to be of lower 
compliance for phase two of the study as that population is more likely to benefit from intervention.  
Although the authors state that participants were recruited from the Wilmer Eye Institute and the 
Scheie Eye Institute, they do not specify how the patients were recruited.   It is possible that there was 
some bias in selection of the recruited patients.   In addition, there was an unspecified number of 
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patients who were lost to follow up during phase two.  Overall, there was a moderate potential for 
selection bias. 
Measurements 
 The Dosing Aid is a valid measuring device that was used in a consistent fashion between the 
intervention and control groups.  However, the participants were aware of the purpose of the Dosing 
Aid during the study which could have created a non-differential bias, artificially inflated the rate of 
compliance in both groups.  This bias towards the null could have decreased the magnitude of effect 
between the two groups.  In addition, it was determined that some patients actually took their drops 
without using the Dosing Aid but the study did not report the number of participants or which arm they 
were in.  Overall, there was a moderately low potential that measurement bias threatens the study’s 
validity. 
Confounding 
 Several factors are potential confounders in this study.  Factors such as education level, age, 
disease duration and severity, race, family history of glaucoma, and general health are all potential 
confounders.  However, multivariate analysis showed only the intervention, a baseline compliance rate 
less than 50%, and white race to be associated with increased compliance.  Overall, there is a low 
potential for confounding. 
Statistical Analysis 
 Okeke et al was the only study in this review to clearly describe the process for sample size 
estimation.  Based on an 80% power with 0.05 alpha to determine a 20% improvement in compliance 
rate they determined a sample size of forty-nine participants per arm for phase two (the intervention 
section) of the study.  However, they had only thirty-five participants in the intervention arm and 31 in 
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the control arm.  Although underpowered they still found a statistically significant increase in adherence 
in the treatment as compared to control group.  Under sampling causes inherent difficulties in 
determining the reliability of the results.  The sixty-six  patients included in the phase two study might 
not adequately reflect the source population.  It is also possible that the researchers would have found 
an even larger improvement in compliance if the study was fully powered.  They did perform a 
univariate and multivariate analysis to determine factors associated with compliance rate.   The 
intervention, low baseline compliance rate, and white race were all associated with increased 
compliance. 
Overall Quality 
 Overall quality rating was determined to be fair.  Although the study was well designed and 
conducted, the potential for sampling error limited its internal validity.   Good internal validity is a 
prerequisite for external validity.  The poor internal validity limits the ability to extrapolate the results to 
external populations.  This study can be generalized with moderate confidence to glaucoma patients 
with a low baseline adherence rate.   The conclusions are congruent with the other RCT included in the 
review which increases the validity of the results.   
Norell Study 
 Norell completed a randomized controlled trial of the effect of a tailored patient educational 
program on glaucoma drop compliance (22). Eighty-two patients with glaucomatous changes who were 
prescribed pilocarpine for chronic open angle glaucoma were recruited from Huddinge University 
Hospital Ophthalmology department between March 1977 and November 1978.  Medication adherence 
was measured for both control and intervention groups using an electronic monitor connected to the 
drop bottle.  The intervention, conducted at the second study visit, consisted of a slide show and 
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handout of glaucoma and treatment information followed by a session with an ophthalmic assistant to 
tailor drop schedule to daily routines. 
 The duration of dose intervals and proportion of missed doses were similar between both 
groups at baseline.  There was a significant difference in change of missed doses after the intervention 
between the two groups (t=2.89, P=0.004).  The percent of missed doses decreased from 10% to 6% in 
the intervention group, while it increased from 10% to 15% in the control group.  The difference in the 
change of dose intervals between the two groups was also significant after the intervention (t=4.60, 
P≈0).  The percent of time exceeding the 8 hour dosing period decreased from 22% to 13% in the 
intervention group and increased from 21% to 24% in the control group. 
 Study Design 
 This RCT examined the short term effect of a tailored educational intervention on the rate of 
glaucoma mediation adherence.  The follow up period after the intervention in this study only lasted 20 
days.  Thus, while the study shows that education can improve compliance in the short term, the effect 
may not last over extended periods.  Randomization of participants to intervention or control is 
mentioned but not described.  One cannot assess the quality of the randomization but because the 
research occurred in 1977, it is safe to assume that it was not a computer generated randomization 
process. 
Selection of Study Population 
 The participants were recruited from the Huddinge University Hospital Ophthalmology Clinic.  
The study population consisted of men and women age 56-90 with chronic simple glaucoma.  The 
authors do not give any additional demographic information.  However, the baseline compliance rate is 
similar between the intervention and control group which suggests some degree of comparability 
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between them.  Nine patients were lost to follow-up after the intervention period.  The authors did 
describe the reasons for loss to follow-up  (six of which were due to equipment malfunction and three to 
unrelated health complications), but did not list which arm the patients were lost from.  It is unlikely 
that patients lost to follow-up because of equipment malfunction raises concern for selection bias.  
However, the hospitalized patients could all have come from the same arm, indicating that the general 
health of one group is different from the other.  Overall, there is a moderate to high potential for 
selection bias based on the minimal information provided by the authors. 
Measurements 
 Compliance was measured by an electronic monitoring device.  The participants were blinded to 
the purpose of the monitoring device until the conclusion of the study, and it was used in the same 
manner in the both the intervention and control groups.  The patient education was performed in a 
consistent fashion.  An ophthalmology assistant assessed patient knowledge and performed individual 
patient tailoring.  Patient tailoring involved the discussion of individual habits, the inclusion of drop 
instillation in habits, and a written list of medication instillation times.  Neither the number of assistants 
used nor their training was described in the article.  Overall, there was a relatively low potential for 
measurement bias. 
Confounding 
 Patients were stratified by age before randomized to either intervention or control group.  The 
authors did not mention controlling for any other potential confounders.  In particular, the issues of 
gender, race, education level, disease duration, nor disease severity were controlled for in the analysis.  
Overall, there was a moderate to high potential for bias due to confounding. 
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Statistical Analysis 
 A t test was used to examine the difference in frequency distribution of missed doses between 
the two groups.  However, as stated above, potential confounders were not taken into account in the 
analysis. 
Overall Quality 
 The overall quality rating of the study was determined to be fair.  The article did not state the 
sample size estimate or give demographic information about the study participants.  While the 
researchers may have addressed some of the issues that would make this study good instead of fair 
quality, the absence of this information in the methods section prevents me from designating a higher 
rating. 
Hoevenaars Study 
 Hoevenaars et al created a questionnaire to examine the correlation between glaucoma disease 
and treatment knowledge and medication compliance (23).  Sixty ophthalmologists identified by their 
membership in the Dutch Ophthalmological Society were randomly selected to participate in the study.  
Each ophthalmologist administered the questionnaire to four consecutive patients.  Information about 
age, gender, duration of glaucoma, and socioeconomic status was collected for all of the participants 
(24). 
 There was not a statistically significant correlation between compliance and total level of 
glaucoma knowledge (P=0.12) or total level of knowledge of glaucoma treatment (P=0.46) or total level 
of need for information (P=0.19).  There was a statistically significant negative correlation between the 
statement “a patient should always tell the ophthalmologist which other medications (s)he is using” 
with an adjusted odds ratio (OR) of 0.1.  This indicates that patients that answer correctly (yes) are 
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actually less compliant, which is surprising.  There was also a statistically significant positive correlation 
(OR 3.3) between a correct answer to the statement “eye drops can repair the damage caused by 
glaucoma” and compliance, indicating that participants who answer correctly (No) are more compliant.  
Three “need for information” statements had a statistically significant positive correlation with 
compliance, indicating that more compliant patients felt they did not need additional information on 
those items.  These items include “how to function better with glaucoma” (OR 3.1), “experiences of 
other glaucoma patients” (OR 3.3) and “heredity of glaucoma” (OR 4.1). 
 Study Design 
 The validity of questionnaire based studies is strongly related to the reliability and validity of the 
questionnaire used. One of the strengths of this study is the systematic development of the 
questionnaire.  Formative research included focus groups, expert opinion and pilot testing.   However, 
even if the questionnaire used is valid, non-response rates and missing data can decrease the internal 
validity of the study.  Hoevenaars, et al. had a physician response rate of 73%.  Response rates of at least 
40-70% do not challenge a study’s internal validity (25).    
Selection of Study Population 
 Sixty ophthalmologists were randomly selected from the Dutch Ophthalmology Society.  It is 
unclear if other ophthalmological societies exist in the Netherlands or if all certified ophthalmologist are 
members of this society.  Selection bias could be present both in the form of the selection of the 
ophthalmologists included in the study and in their selection of the patient participants which were 
selected in a consecutive fashion.  Of the sixty ophthalmologists who were recruited, 73% responded to 
the invitation for a total of 166 patients completing the questionnaire.  The demographics of neither the 
ophthalmologists nor the patients were described in the article, however it was stated that both 
glaucoma specialists and general ophthalmologists were included.  It is likely that the patient 
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populations of the specialists and general ophthalmologists were very different.  The overall potential 
for selection bias was high. 
Measurements 
 The questionnaire was systematically developed using focus groups, expert opinion and pilot 
tests.  Cronbach’s alpha was 0.83 which indicated good internal consistency of the questionnaire.  
Compliance was self-reported on the questionnaire.  Researchers minimized recall bias by limiting the 
compliance time period to the previous four weeks.  Potential reporting bias of compliance rates was 
minimized by using a strict noncompliance definition of missing one or more drops in the previous four 
weeks.  The overall potential for measurement bias was low to moderate. 
Confounding 
 The authors calculated adjusted odds ratios (OR) taking age, gender, duration of disease, 
educational level, glaucoma medications and history of prior glaucoma surgical treatment into 
consideration.  However, disease severity, race, nor family history of glaucoma was explicitly controlled 
for in the analysis.  Overall, the potential for confounding bias was low to moderate. 
Statistical Analysis 
 Significance was appropriately tested for using a Pearson chi-squared test.  Logistic regression 
was performed for each item on the questionnaire to calculate the OR for being compliant.  Due to the 
high number of testing (fifty-nine total items on the questionnaire), it is highly likely that some of their 
results are due to chance.   
Any missing data were categorized as “don’t know/no opinion.”  However, the researchers do 
not state how many time items were classified in this manner.  In addition, for the eleven participants 
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who did not answer how often they had missed their eye drops, the researchers classified the 
participant as noncompliant or compliant based on their answers to other questions.   
Overall Quality 
 The Hoevenaars study received an overall quality grading of fair.  The potential biases in the 
selection of both ophthalmologist and participants strongly affect its internal validity.  Although the 
questionnaire itself appears to be reliable, the overall conclusions of the study do not agree with the 
conclusions of other studies, calling their results in question.  The Netherlands are very ethnically 
homogenous which limits this study’s applicability to the very heterogeneous US population.    
Discussion 
 Both RCTs found an educational intervention to statistically improve compliance to medications 
in glaucoma patients.  Although the results were statistically significant, the clinical significance remains 
unclear.  Additionally, both trials involved multifaceted educational programs. It is difficult to determine 
the extent to which each component contributed to the increased compliance.  Each study defined 
compliance differently, making it challenging to compare them directly.  All studies received an overall 
quality grading of fair due to multiple potentials biases and limitations of external validity. 
 Despite these limitations both RCTs found the intervention to improve compliance.  The 
interventions in the two trials included both knowledge and behavioral modifications.  Hoevenaars et al 
conclude that education only based programs are unlikely to improve compliance, but that more 
complex interventions combining patient education, behavior modification, and patient belief systems 
would be more effective (23).   
Both RCTs examined the effect of the intervention in the short term, from twenty days (22) to 
three months (21).  Although we see a short term improvement in adherence, there are many 
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unanswered questions about long term effect.  Both the frequency and composition of the intervention 
are important factors to consider and may change throughout the duration of disease management.   
This is especially important in regards to glaucoma which is a chronic disease often requiring lifelong 
medical therapy. 
Additionally, all three studies used medication adherence to measure intervention success.  
However, adherence is an intermediate outcome and may not accurately reflect patient centered health 
outcomes such as vision and quality of life (QoL).  Glaucoma progression is correlated with a decrease in 
both disease specific and general QoL (26).  Future research should focus on the long term effects of 
multifaceted behavioral and education based interventions on the prevention of glaucomatous visual 
field loss and preservation of QoL.  No published studies to date have examined the effect of this type of 
intervention on long term disease progression or QoL. 
Although this was a systematic and fairly thorough review, it was not completely 
comprehensive.  Thus, it is possible that literature on this topic was not captured in this search.  The 
review was limited to studies in the English language but there may be studies published in other 
languages that address the topic of this review.   Additionally the review was limited to published 
literature.  Ongoing studies and unpublished articles were not included which limited the completeness 
of the review. 
Conclusion 
 Although a few studies have examined the effect of education on glaucoma medication 
compliance, many of the recommendations are extrapolated from other chronic diseases such as 
hypertension and diabetes.  While it is likely that many of the concepts are also applicable to glaucoma 
patients, the use of eye drops as opposed to oral medications could create different issues not 
addressed in other chronic diseases.  As of May 2011 there are three studies with specific 
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behavioral/educational interventions listed on the National Institutes of Health (NIH) website (27).  
Although it is most likely that a multifaceted approach will be the most efficacious, it would be 
worthwhile to examine which specific components of an educational program are most beneficial. 
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Table 1. Evidence Summary Table 
Citation Study design population Intervention outcomes results Strengths/weaknesses 
Quality 
grading 
Okeke, et al. 
Interventions 
Improve Poor 
Adherence with 
Once Daily 
Glaucoma 
Medications in 
Electronically 
Monitored patients. 
Ophthalmology.200
9; 116: 2286-2293.  
RCT 
Glaucoma patients 
treated with a 
prostaglandin 
analog at Scheie Eye 
Institute or Wilmer 
Eye Institute 
between 11/06-
6/07 
Educational 
video & session 
with study 
coordinator, 
reminder phone 
calls, audio and 
visual dose 
reminders 
Change in drop 
compliance 
Intervention 
group had a 
19% increase 
in adherence 
(P<0.0001); 
control group 
had 6% 
increase in 
adherence 
(P=0.19) 
Study was well 
designed but 
underpowered; study 
was 3 month duration 
so we don’t know long 
term effect 
fair 
Hoevenaars, et al. 
Will improvement of 
knowledge lead to 
improvement of 
compliance with 
glaucoma 
medication? Acta 
Ophthalmol. 2008; 
86: 849-855. 
Questionnaire 
Patients of 
members or the 
Dutch 
Ophthalmological 
Society 
NA 
Correlation 
between 
compliance and 
glaucoma 
knowledge 
No statistically 
significant 
correlation 
between  
compliance  
and total 
glaucoma 
knowledge 
(P=0.12), total 
glaucoma 
treatment 
knowledge 
(P=0.46), OR 
total need for 
information 
(P=0.19) 
Questionnaire was 
systematically 
developed and has a 
Cronbach’s alpha 
coefficient of 0.83 
Fair 
Norell, S.E. 
Improving 
medication 
compliance: a 
randomized clinical 
trial. British Medical 
Journal. 1972; 2, 
1031-1033. 
RCT 
Patients treated for 
simple chronic 
glaucoma with 
pilocarpine at 
Huddinge University 
Hospital 
Patient tailored 
educational 
program  
Change in drop 
compliance 
Proportion of 
missed doses 
was 
significantly 
few in the 
intervention 
group 
compared to 
the control 
group (P=.004)  
Study does not 
describe demographics 
of study population so 
uncertain of external 
generalizability 
fair 
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Table 2. Quality Scoring 
1
st
 author, 
Year 
Source and 
sample 
population 
adequately 
described 
Cases 
and 
controls 
similar 
at 
baseline 
Adequate 
description of 
measurement 
tool 
Appropriate 
analysis 
Adequately 
reported 
results 
External 
validity 
Overall 
quality 
score 
(x/18) 
Okeke, 2009 3 2 3 2 2 1 13/18 
Hoevenaars, 
2008 
1 NA 3 2 3 1 10/15 
Norell, 1979 1 2 2 2 2 2 11/18 
Poor=1, fair=2, good=3 
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Figure 1. Article Selection Flow Diagram  
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Appendix 1: Search Strategy 
PubMed: 
1. Communications 
2. Health education 
3. Health status 
4. Patient compliance  
5. Physician patient relations 
6. Patient compliance AND physician patient relations AND glaucoma  
7. Communications OR health education AND physician patient relations AND patient 
compliance AND glaucoma 
CINAHL: 
1. Patient compliance AND health education AND physician patient relations 
EMBASE:  
1. Communications OR health education AND physician patient relations AND patient 
compliance AND glaucoma 
ISI: 
1. Communication AND patient compliance AND physician patient relations 
Cochrane:  
1. Patient provider communication 
2. Health literacy  
3. Adherence AND intervention 
4. Provider communication AND literacy 
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Appendix 2: Critical Appraisal Form 
  
Citation (JAMA style)  
 
Study Question and  Research Design  
Source Population  
 
Study Population (descriptive: demographics, eligibility 
criteria) and how chosen (volunteers, recruitment, tertiary 
care clinics, population-based, etc.) 
 
 
Initial Comparability of groups (i.e., randomization or group 
composition; concealment of allocation) 
 
 
 
Drop outs (no endpoint data), adherence, crossovers 
(attrition, loss to follow up) 
 
Potential for selection bias (+ to +++) and explain  
 
 
Measurement of exposure, intervention, potential 
confounders, and outcomes; reliability and validity of 
measurement; how performed, blinding 
 
Potential for measurement bias (+ to +++)  
 
 
Potential confounders (name and describe how each was 
controlled for) 
 
 
 
Potential for confounding (+ to +++)  
 
 
Analysis (intention to treat or other adjustment)  
Results: magnitude and direction (point estimate; random 
error or precision (confidence interval); statistical 
significance 
 
Clinical and Public Health importance for the source 
population; for a wider population 
 
Overall judgment of internal validity (good, fair, poor)  
External validity: applicability to other populations  
Comments and overall conclusions/interpretation (include 
consistency with other studies; biologic plausibility; conflicts 
of interest; selective endpoint reporting) 
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Study Abstract 
Purpose:  Glaucoma, a chronic progressive disease is initially asymptomatic.  Vision loss, which typically 
begins in the periphery of the visual field, is irreversible once it has occurred.  Adherence to ocular anti-
glaucoma drops is important to prevent the progression of vision loss and ultimately blindness.  The 
purpose of the described study is to examine how African Americans perceive medical information 
related to glaucoma care from their providers.  The ultimate goal is to use this information to develop a 
tool for improving provider patient communication about glaucoma and its treatment.  
Methods:  A qualitative study using focus groups was designed to explore the interactions between 
provider and patient used to impart disease related information.  Low health literacy African American 
patients recruited from the eye clinic at UNC Chapel Hill will attend one of three focus groups of six to 
eight individuals each.  Qualitative and quantitative data will be analyzed using Atlas.ti.60 and STATA 
10.1, respectively. 
Anticipated Results: Several major themes are expected to emerge from the focus groups.  The first is 
education using multiple media formats (verbal, written, and graphic) appropriate to health literacy 
level.  It is expected that provider patient relationship can be improved through the exploration of 
patient beliefs and attitudes towards disease.  Multiple communication skills such as motivational 
interviewing, ask-tell-ask dialogue, and assessing readiness for change, likely can be used to identify and 
address patient adherence.  
Conclusion:   Improving patient adherence is likely to need a multifaceted, individualized approach.  
However, the identification of patient beliefs, values and learning style are an important first step in 
determining an individualized educational plan.
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Introduction 
Primary open-angle glaucoma (POAG), a chronic progressive optic neuropathy, affects 
approximately 2.22 million adults in the United States (1).  POAG affects a disproportionally higher 
percentage of African-Americans with as much as a six fold increase in prevalence in some age groups 
when compared to their White counterparts (2, 3).  The onset of POAG occurs on average ten years 
earlier and progresses more rapidly in African Americans than other races (2). 
In one study, lack of knowledge about glaucoma was found to be the most important barrier to 
care in predominately African American populations (4).  Lack of knowledge about one’s medical 
condition has been linked to lower health literacy. Health literacy is the ability to read and understand 
written health information, oral health information, and the ability to act on such information (5).   The 
concept of health literacy in disease management is beginning to permeate the field of ophthalmology.   
Not only is low health literacy correlated with poorer understanding of disease, but it is also associated 
with lower compliance to medical treatment and worse health outcomes (6-10).   
A cross-sectional patient survey of 197 patients with open angle glaucoma found that 52% read 
at or below eighth grade level and 11.7% were at or below third grade reading skills (11).  In addition, 
the researchers found a correlation between poorer literacy skills and lower medication adherence, 
measured by the number of prescription refills (11).  Lower health literacy is more prevalent among the 
lower socioeconomic urban population, which is predominately African-American (11).  A review of 
educational material produced by the American Academy of Ophthalmology (AAO) in 1997 found that 
only 32% of the material was written at or below an eighth grade reading level (12).  The overall mean 
Flesch-Kincaid score of the material was 9.6 (12).  In contrast, AAO educational material published in 
2008 improved to a mean score of 8.0 on the Flesch-Kincaid Grade Level Scale (13).   
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Barriers to effective patient care can be grouped into four basic categories: medication regimen, 
patient factors, provider factors, and situational factors (14) (15).  While multiple studies have 
addressed the issue from the perspective of medication adherence, additional studies are needed to 
explore these basic categories in order to tailor interventions to patients’ needs.  Specifically, tools to 
improve ophthalmologists’ ability to communicate effectively with low literacy patients are lacking. 
Although it is unknown whether poor health literacy is a causal mechanism for worse disease 
outcomes or a marker for presently unknown factors, the provider-patient interaction has been 
identified as a modifiable step along the causal pathway to improved disease outcomes (10).  Therefore, 
the goals of the planned study are to understand how African Americans perceive medical information 
related to glaucoma care.  The information will then be used to develop a tool for improving provider-
patient communication about glaucoma.      
Methods 
Approach 
This qualitative study will use grounded theory to explore provider and patient  interactions that 
are used to impart disease information.   Focus groups will be used to extract patient perspectives on 
the form and content of information their ophthalmologists could better provide to help them 
understand glaucoma and their role in glaucoma management.   There will be a series of three focus 
groups consisting of six to eight participants with a goal of twenty-four total participants.  All three 
groups will be asked a series of scripted questions, including several open ended questions (Appendix 1).  
The moderator can use probe questions at his/her discretion to explore participant responses.  Probe 
questions are expected to vary across the groups, according to individual situations.   A retrospective 
chart review will be used to determine disease severity and demographic information of each 
participant.  A validated questionnaire (16), along with a confirmation letter, mailed to participants prior 
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to the focus group will be used to collect data on perceived glaucoma education and compliance 
(Appendix 2).   The study will be approved by the Institutional Review Board prior to study initiation and 
informed consent will be obtained from all participants. 
Setting 
The participants will consist of African Americans previously seen at the glaucoma or resident 
clinic at Kittner Eye Center of UNC Chapel Hill.  Clinic schedules will be reviewed daily to identify 
potential participants by age and disease status.  Participants will be recruited and screened by UNC 
School of Medicine (SOM) medical students at the time of their regularly scheduled glaucoma 
appointment using a predetermined script (Appendix 3).   It is estimated to take approximately two 
weeks per focus group to enroll the six to eight participants.  Participants will be told that researchers 
seek to hear from patients on “physician-patient communication issues.”  Due to the sensitive nature of 
the term “low literacy,” participants will not be explicitly told about the literacy component of the study.  
One African American trained focus group moderator will facilitate open and interactive dialogue 
amongst the group members and monitor the participation of each group member.  One trained 
medical student will serve as note taker for each focus group to capture major themes and group 
dynamic information.  The groups will be held in a neutral location on the campus of UNC-Chapel Hill. 
Sampling 
Convenience sampling will be used to identify potential participants who receive care at UNC 
Kittner Eye Center.  Ophthalmology clinic schedulers will be blinded to the nature of the study to 
decrease bias in scheduling patients for their regular clinic appointments.  Patients will be eligible if they 
are age 18 years or older, have a diagnosis of primary open angle glaucoma for at least six months, or 
have inadequate or marginal level functional health literacy.  Functional health literacy will be 
determined at screening using the Short Test of Functional Literacy in Adults (STOFHLA), a validated and 
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reliable measure of health literacy.  Patients will be excluded if their best corrected vision is worse than 
20/50 in their better eye, a Mini Mental Status Exam (MMSE) worse than 25 or a documented 
psychiatric disorder, or a significant hearing disability. Decreased vision, low level score on MMSE , 
psychiatric disorders or hearing disabilities could interfere with a person’s ability to complete the 
literacy test or to interact with participants during the focus groups.  Interested participants will be seen 
by a researcher to screen for eligibility criteria.   The general consensus in qualitative research is that 
expected information saturation occurs by the third focus group.  This theory  was used as the rationale 
for a sample size of three focus groups. 
Information Collection and Analysis 
Data will be collected from chart reviews, a questionnaire administered via mail prior to the 
focus group, field notes collected by the assistant moderator, and transcription from the group audio 
recording.   Quantitative data collected from the chart review and questionnaire will be analyzed using 
STATA 10.1.  Qualitative data collected from the field notes and audio transcription is to be analyzed 
using Atlas.ti 6.0 for emerging themes used to describe and explore provider and patient interactions.   
Computer assisted analysis is used to increase standardization and efficiency of analysis.  Dependability 
of data will be established by the use of transcribed audio recordings of focus group sessions.  
Interobserver reliability will be established through the use of a debriefing session at the end of each 
focus group between the moderator and assistant moderator.  This debriefing session will be audio 
recorded and included in data analysis.  Data will be coded based on the identified themes and ideas.  
Data sets will be coded independently by two different analysts and resultant codes compared.  After 
completing analysis, the two coders will meet to discuss the results and address any discrepancies which 
will be resolved by consensus reached by the two analysts.  
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Expected Results 
Although scarce literature exists examining the effects of patient education on adherence in 
glaucoma, several ophthalmologists have written editorials presenting guidelines for both the detection 
and management of adherence issues based on researched gathered from other chronic diseases such 
as hypertension and diabetes (17, 18) .  The use of verbal, written and graphic instructions can enhance 
understanding (19)(20).  Health literacy should be a major consideration while constructing the written 
information as over ninety million Americans have limited literacy skills (5).  The reading grade level of 
current American Academy of Ophthalmology (AAO) patient education material ranges from 4.9 to 11.1 
with a mean of 8.0 (13) but 44 million American read at only the 5th grade level (21). 
Provider patient relationship is an important part of the path to adherence (22).  Motivational 
interviewing has been used successfully in other fields of medicine and has been suggested to be useful 
in nonadherent glaucoma patients.  Although physicians assess for nonadherence, many factors cause 
patients to underreport medication adherence (23).   Reported education centered barriers to 
adherence include insufficient understanding of drop installation, drop regimen, the consequences of 
poor drop adherence and inadequate education (24-26). 
 Several communication based strategies have been suggested, such as using an “Ask-Tell-Ask” 
dialog (13, 23, 27, 28), motivational interviewing (28), assessing for readiness for change (28), and “Ask 
Me 3” (27).  More passive learners are less likely to ask questions (15), so a communication strategy 
forcing patients to interact with their physicians such as “Ask Me 3” or “Ask-Tell-Ask” could encourage 
greater disease comprehension and more open dialogue between the physician and patient. 
In addition, valuable information can be gathered from examining the health beliefs and values 
of African Americans concerning other diseases.  Lack of concern over vision loss is associated with 
decreased adherence to glaucoma medications and medical appointments in both white and nonwhite 
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patients (15).  African American patients state that trust, empathy, and good communication is 
important in their interactions with physicians (22).   
Potential Difficulties 
 Targeting recruitment to low literacy patients could cause enrollment to be slower than initially 
estimated.  Unfortunately, a stigma still exists around the issue of low literacy.  Patients with low literacy 
might be less willing to participate due to embarrassment of literacy skills. The presentation of the study 
will be very important to avoid a negative depiction of the low literacy demographic we are seeking to 
enroll.  If slow enrollment continues to be a problem, we can choose to also include patients at Duke 
Ophthalmology Clinic or private practices in the area. 
Although we plan to send out a confirmation letter with directions and a reminder phone call, 
committed participants may not actually show up for the focus group.  This can be due to a number of 
factors and is a known phenomenon.   Over recruitment is a common solution to this problem.  We aim 
to have six to eight participants for each focus group so we will enroll ten participants to ensure that we 
have enough participants to run the focus group.  We will offer monetary incentive of fifteen dollars per 
participant to encourage confirmed individuals to attend the session.  In addition, we will be sure to 
hold the focus group in a location that is convenient to most participants and near a form of public 
transportation. 
Discussion 
 Improving patient adherence is likely to need a multifaceted approach, with patient centered 
education as only one part of the puzzle.  Additional approaches, such as lowering costs and simplifying 
treatment regimens are also important.  The Glaucoma Adherence and Persistency Study (GAPS) 
identified different types of learners: doctor dependent, who learn all their information from physicians; 
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collaborative, who learn most of their information from physicians; and doctor independent, who learn 
very little from his/her doctor.  These three types of learners report their physician encounters 
differently, with doctor dependent learners less likely to report their physicians confirming their 
understanding (15).  In addition, doctor dependent learners had lower adherence rates.  These patients 
would likely benefit from a more aggressive approach to patient education from their physicians. 
Findings from GAPS support the theoretical models of adherence behaviors showing doctor-
patient communications, doctor-patient relationship, and health related beliefs to be important 
predictors of adherence (15).  Identifying patient beliefs and attitudes along with their style of learning 
is an important first step in the patient encounters.  Physicians must also be appropriately trained to 
modify their interactions depending on patient preference.  This individualized approach makes one 
uniform communication tool difficult to construct.  A potentially more useful tool would be a general 
guideline based on the assessment of patient learning style and health beliefs. 
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Table1: Participant Demographics 
Demographic Group 1 Group 2 Group 3 
Age    
Gender 
  Female 
  Male 
   
Educational Attainment 
   High School or less 
   Some College 
   College Graduate 
   
Duration of Disease    
Number of Glaucoma 
Medications 
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Table 2: Questionnaire Results 
Question 
Percent answering 
correctly 
Glaucoma is a disease that affects your eyes and no other part of the body  
Most glaucoma is painful  
Raised eye pressure can cause glaucoma  
Glaucoma affects central vision before side vision  
Vision loss in glaucoma usually occurs very quickly  
Glaucoma can be cured  
The most common treatment for glaucoma is surgery  
Lost eyesight from glaucoma can be restored  
Most people with glaucoma go blind  
Treatment for glaucoma is life long  
Regular check-ups are not necessary for glaucoma patients  
Glaucoma can run in families  
Glaucoma is more common as you get older  
Most people will have symptoms that warn them their glaucoma is getting worse  
Stress can make glaucoma worse  
A healthy diet slows the progression of glaucoma  
Using a computer will make glaucoma worse  
Fluorescent lights will make glaucoma worse  
Eye drops can have side-effects that affect other parts of the body  
Watering eyes indicates that there is a build-up of fluid inside the eyes  
A lot of reading may make glaucoma worse  
Lower the eye pressure is a treatment that slows the worsening of glaucoma  
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Appendix 1: Focus Group Question Guide 
1. Opening question/icebreaker 
2. Where have you learned the most about glaucoma? 
3. What is it like when you ask your glaucoma doctor questions about your medical care? 
4. What questions do you have about your care after you leave your doctor’s office? 
5. What would help you follow the doctor’s directions after you leave the office? 
6. How do you learn best?  Think of hearing versus reading versus seeing a picture. 
7. What is the most important thing you learned about your disease from your doctor? 
8. Is there anything else that we haven’t talked about yet that you think we should have 
addressed? 
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Appendix 2: Glaucoma knowledge questionnaire (43) 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
Appendix 3: Recruitment Script 
Eligibility Criteria: 
• ICD-9 diagnosis of primary open angle glaucoma for ≥6 months 
• ≥18 years old 
• Gender balance (no fewer than 3 men or women in each group) 
• Inadequate or marginal functional health literacy as determined by the Short Test of Functional 
Literacy in Adults (STOFHLA) 
 
Exclusion Criteria: 
 
• Adequate functional health literacy as determined by STOFHLA 
• Best corrected vision worse than 20/50 in better eye 
• Mini Mental Status Exam (MMSE) worse than 25 
• Documented psychiatric disorder 
• Significant hearing disability 
 
Script:  
Hello Mr./Mrs. _____.   My name is [your full name] and I am working on a research project here at 
UNC.  We are holding focus groups to talk about issues in physician patient communication in patients 
with glaucoma and would like you to be a part of that.  This is a group interview that would last about 
two hours, and we would pay you $25 for your time. 
You would get together with other African American patients with glaucoma to talk together and answer 
some questions for us.  There will be just this one meeting. 
Is this something that interests you? 
The session we are trying to set up is one [day] at [time].  Is this something that could fit into your 
schedule? 
If the participant is available, continue with background information:  
We are putting together a group of people who are willing to discuss their opinions and experiences 
with physician communication.  We are especially interested in finding what people in the African 
American community think about the topic.  Does this sound like something that would work for you? 
Scheduling:  
The session would be at [location] on [date].  We will start at [time] and end by [time].   It is very 
important that everyone that signs up actually shows up.  Do you think that you can come?  It is also 
important that you will be there by [start time].  Will you have any trouble getting there on time? 
The group itself will consist of 6-8 people, all African Americans with glaucoma.  Most of the time will be 
spent talking amongst yourselves in a group discussion.  The group session will be audio recorded to 
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make sure that we have a good idea of what was said.  The recording and all that was is said during the 
session will be kept confidential.  Attending this session is completely voluntary and you will be free to 
leave at any time for any reason.   
I’d like to mail you a letter confirming your participation in this focus group, along with a map to the 
group location, and a survey to complete and bring along with you to the focus group session.  What is 
the best address to send that to? 
We will be starting the session right on time at [time] on [date]. If you get to the session late we may not 
be able to include you.  So, it is very important that you get there on time. 
So that everyone remembers, we will be calling you the evening before the group session to remind you 
about it.  What is the best number to call you at?  
Thank you very much.  We are looking forward to seeing you on [date]. 
If the patient is unsure whether to participate: 
First, make sure that the time is workable for that person.  Do not waste time trying to recruit someone 
who won’t be able to attend.  If person is potentially available, offer to call them in a few days if you still 
have an opening in the group.  It is very important that all participants show up to the focus group 
session.  Only accept people who make a solid commitment to attend.  If the person would like to 
participate but the group has filled up, you can offer the role of an alternate.  An alternate can be called 
the evening before the group if a participant cancels at the last minute. 
 
 
 
 
 
 
 
 
 
 
 
 
